Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study

Automated identification of cell populations in flow cytometry data with transformers

(2022) Matthias Wodlinger et al.   COMPUTERS IN BIOLOGY AND MEDICINE

CD34+CD19-CD22+ B-cell progenitors might underlie phenotypic escape in patients treated with CD19-directed therapies

(2022) Clara Bueno et al.   BLOOD

Machine learning optimized multiparameter radar plots for B‐cell acute lymphoblastic leukemia minimal residual disease analysis

(2022) Kevin E. Shopsowitz et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

B‐lineage antigens that are useful to substitute CD19 for minimal residual disease monitoring in B cell precursor acute lymphoblastic leukemia after CD19 targeting

(2022) Ekaterina Mikhailova et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche

(2022) Alessandra Fallati et al.   Cancers

Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient Outcome

(2022) Elen Oliveira et al.   Cancers

Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease

(2021) Ekaterina Mikhailova et al.   BRITISH JOURNAL OF HAEMATOLOGY

CD19 CAR-T cell treatment conferred sustained remission in B-ALL patients with minimal residual disease

(2021) Wenyi Lu et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Current Status of CAR T Cell Therapy for Leukemias

(2021) Katherine Harris et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Flow cytometric minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukaemia patients treated with CD19‐targeted therapies — a EuroFlow study

(2021) Martijn W. C. Verbeek et al.   BRITISH JOURNAL OF HAEMATOLOGY

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report

(2021) Margarita Maurer-Granofszky et al.   Cancers

Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy

(2020) Diane Libert et al.   LEUKEMIA

Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

(2020) Ludovic Lhermitte et al.   MODERN PATHOLOGY

Automated Flow Cytometric MRD Assessment in Childhood Acute B‐ Lymphoblastic Leukemia Using Supervised Machine Learning

(2019) Michael Reiter et al.   CYTOMETRY PART A

From big flow cytometry datasets to smart diagnostic strategies: The EuroFlow approach

(2019) C.E. Pedreira et al.   JOURNAL OF IMMUNOLOGICAL METHODS

EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets

(2019) Juan Flores-Montero et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Immunophenotypic dissection of normal hematopoiesis

(2019) Alberto Orfao et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Accurate quantification of fourteen normal bone marrow cell subsets in infants to the elderly by flow cytometry

(2018) Julie Pont et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma

(2017) J Flores-Montero et al.   LEUKEMIA

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

(2016) Prisca Theunissen et al.   BLOOD

A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy

(2016) Sindhu Cherian et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

(2015) J. J. M. van Dongen et al.   BLOOD

Detection of minimal residual disease in B lymphoblastic leukemia using viSNE

(2015) Joseph A. DiGiuseppe et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Detection of minimal residual disease in pediatric acute lymphoblastic leukemia

(2013) Giuseppe Gaipa et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Overview of clinical flow cytometry data analysis: recent advances and future challenges

(2013) Carlos E. Pedreira et al.   TRENDS IN BIOTECHNOLOGY

Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data

(2011) Karel Fišer et al.   CYTOMETRY PART A

Redirecting Specificity of T-Cell Populations For CD19 Using the Sleeping Beauty System

(2008) H. Singh et al.   CANCER RESEARCH